Theseus Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Theseus Pharmaceuticals generated cash of -$32,945,000, which is less than the previous year. Cash used in financing activities reached the amount of $182 last year. Net change in cash is therefore -$150,057,000.
Cash Flow
| 2019 | -4.80M | 0 | 2.99M |
|---|---|---|---|
| 2020 | -4.85M | 0 | 11.99M |
| 2021 | -27.19M | 12K | 263.77M |
| 2022 | -32.94M | -117.29M | 182 |
THRX Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 245.04M | 8.45M | 1.31M | 3.13M |
Operating activities | ||||
Net income | -50.60M | -27.30M | -11.99M | -7.18M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 50K | 2K | 2K | 2K |
Stock-based compensation expense | 11.41M | 4.36M | 1.05M | 317K |
| Deferred income tax benefit | 11.41M | 4.36M | 1.05M | 317K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 3.97M | -150K | 849K | 193K |
Cash generated by operating activities | -32.94M | -27.19M | -4.85M | -4.80M |
Investing activities | ||||
Purchases Of Investments | -191.43M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -455K | 12K | 0 | 0 |
Acquisitions Net | 116.83K | 0 | 0 | 0 |
Cash generated by investing activities | -117.29M | 12K | 0 | 0 |
Financing activities | ||||
Common Stock Issued | 0 | 166.24M | 11.99M | 2.99M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 |
Cash used in financing activities | 182 | 263.77M | 11.99M | 2.99M |
Net Change In Cash | -150.05M | 236.58M | 7.14M | -1.81M |
Cash at end of period | 94.98M | 245.04M | 8.45M | 1.31M |
| Data source | Data source |